NT Pro BNP is a modifiable biomarker in patients with congestive heart failure and has been shown to be an important marker of illness for these subsets of patients during the COVID-19 pandemic, even in the absence of heart failure.16, 17, 18,24 Elevated troponins are also common in these patients and predict poor outcomes.20 The gene discussed is NPPB; the disease is heart failure.